NCT06851533 Comparing Thoracolumbar Interfascial and Quadro Iliac Plane Blocks on Postoperative Opioid Use Following Lumbar Microsurgery
| NCT ID | NCT06851533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Lumbar Microdiscectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2026-03-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-03-10 with a primary completion date of 2026-03-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lumbar microdiscectomy is a commonly used surgical procedure for treating herniated discs. Effective postoperative analgesia is crucial for early mobilization and functional recovery. Uncontrolled postoperative pain can delay recovery, increase the risk of opioid dependence, and lead to respiratory complications. Although opioid analgesics effectively reduce pain, they can cause side effects such as nausea, vomiting, respiratory depression, and dependency. Therefore, non-opioid analgesic methods are preferred for patient safety and comfort. Recently, regional anesthesia techniques such as the Thoracolumbar Interfascial Plane (TLIP) block and the Quadro Iliac Plane Block have been introduced for postoperative pain management in lumbar surgeries. However, there are not enough studies comparing the superiority of these two methods. Study Objective: The primary aim of this study is to evaluate the effects of ultrasound-guided TLIP and Quadro Iliac Plane Blocks on postoperative opioid consumption after lumbar microsurgery. The secondary aim is to compare opioid-related side effects (such as nausea, vomiting, respiratory depression, etc.) and postoperative NRS pain scores between the groups.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 to 80 years * American Society of Anesthesiologists (ASA) physical status I to III * scheduled for lumbar microdiscectomy surgery Exclusion Criteria: * Known allergy to local anesthetics * Any other significant drug allergies related to the study interventions * Pregnancy * Pre-existing psychiatric or neurological disorders * Inability to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06851533 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Lumbar Microdiscectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06851533 currently recruiting?
Yes, NCT06851533 is actively recruiting participants. Contact the research team at burakomur@outlook.com for enrollment information.
Where is the NCT06851533 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06851533 clinical trial?
NCT06851533 is sponsored by Medipol University. The trial plans to enroll 90 participants.